Multicentre imaging measurements for oncology and in the brain

British Journal of Radiology

Volumn 84, Issue SPEC. ISSUE 2, 2011, Pages

  Tofts, P S ^a,b   Collins, D J ^c  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM; DIAGNOSTIC AGENT; TUMOR MARKER;

ARTERIAL SPIN LABELLING; ARTICLE; BRAIN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; IMAGING PHANTOM; MAGNETISATION TRANSFER RATIO; MULTICENTER STUDY (TOPIC); NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOLOGICAL PARAMETERS; REPRODUCIBILITY; SPIN LABELING; STATISTICAL ANALYSIS; THERMOREGULATION; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME; WHITE MATTER; BRAIN MAPPING; CHEMISTRY; CROSS-SECTIONAL STUDY; IMAGE ENHANCEMENT; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOLOGY; REVIEW;

BRAIN MAPPING; BRAIN NEOPLASMS; CONTRAST MEDIA; CROSS-SECTIONAL STUDIES; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MEDICAL ONCOLOGY; MULTICENTER STUDIES AS TOPIC; PHANTOMS, IMAGING; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 84867196530     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/74316620     Document Type: Article

References (108)

1. Tofts PS. Standardisation and optimisation of magnetic resonance techniques for multicentre studies. J Neurol Neurosurg Psychiatry 1998;64:S37-43. (Pubitemid 28274435)
2. Tofts PS. QA: Quality assurance, accuracy, precision and phantoms. In: Tofts PS, ed. Quantitative MRI of the brain: measuring changes caused by disease. Chichester, UK: John Wiley, 2003:55-81.
3. Tofts PS. The measurement process: MR data collection and image analysis. In: Tofts PS, ed. Quantitative MRI of the brain: measuring changes caused by disease. Chichester, UK: John Wiley, 2003:17-54.
4. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measure-ment. Lancet 1986;1:307-10. (Pubitemid 16134762)
5. Bland JM, Altman DG. Measurement error. BMJ 1996; 312:1654. (Pubitemid 26229459)
6. Grimaud J, Lai M, Thorpe J, Adeleine P, Wang L, Barker GJ, et al. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted tech-niques. Magn Reson Imaging 1996;14:495-505. (Pubitemid 26274841)
7. Filippi M, Horsfield MA, Tofts PS, Barkhof F, Thompson AJ, Miller DH. Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 1995;118:1601-12. (Pubitemid 26011928)
8. Barker GJ, Schreiber WG, Gass A, Ranjeva JP, Campi A, van Waesberghe JH, et al. A standardised method for measuring magnetisation transfer ratio on MR imagers from different manufacturers\the EuroMT sequence. Magn Reson Mater Phy 2005;18:76-80. (Pubitemid 40767697)
9. Filippi M, Gawne-Cain ML, Gasperini C, vanWaesberghe JH, Grimaud J, Barkhof F, et al. Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis. Neurology 1998;50:238-44. (Pubitemid 28106048)
10. Filippi M, Horsfield MA, Ader HJ, Barkhof F, Bruzzi P, Evans A, et al. Guidelines for using quantitative measures of brain magnetic resonance imaging abnorm-alities in monitoring the treatment of multiple sclerosis. Ann Neurol 1998;43:499-506. (Pubitemid 28231726)
11. Jasperse B, Valsasina P, Neacsu V, Knol DL, De SN, Enzinger C, et al. Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manu-ally-edited SIENA and SIENAX. J Magn Reson Imaging 2007;26:881-5. (Pubitemid 47548146)
12. Tofts PS, Steens SC, Cercignani M, Admiraal-Behloul F, Hofman PA, van Osch MJ, et al. Sources of variation in multi-centre brain MTR histogram studies: body-coil transmis-sion eliminates inter-centre differences. MAGMA 2006;19: 209-22. (Pubitemid 44438436)
13. D'Arcy JA, Collins DJ, Padhani AR, Walker-Samuel S, Suckling J, Leach MO. Informatics in Radiology (infoRAD): Magnetic Resonance Imaging Workbench: analysis and visualization of dynamic contrast-enhanced MR imaging data. Radiographics 2006;26:621-32. (Pubitemid 43515329)
14. Mulkern RV, Forbes P, Dewey K, Osganian S, Clark M, Wong S, et al. Establishment and results of a magnetic resonance quality assurance program for the pediatric brain tumor consortium. Acad Radiol 2008;15:1099-110.
15. Jackson JS, Tozer D, Tofts PS. Rapid measurement of subtle sub-one-percent changes in transmitter output and receive gain to monitor scanner stability. Proceedings of the International Society Magnetic Resonance in Medicine, 14th annual meeting, Seattle. 2006; 2363.
16. Jackson JS, Tozer D, Tofts PS. Measurement of subtle scanner instability using a stable thermally-insulated phantom. Proceedings of the International Society Magnetic Resonance in Medicine, 13th annual meeting, Miami. 2005; 2290.
17. Dowell NG, Tofts PS. Simple Reliable and Precise Quantitative Quality Assurance of in-vivo Brain ADC Proceedings of the International Society Magnetic Resonance in Medicine, 16th annual meeting, Toronto. 2008; 3152.
18. Tofts PS, Lloyd D, Clark CA, Barker GJ, Parker GJ, McConville P, et al. Test liquids for quantitative MRI measurements of self-diffusion coefficient in vivo. Magn Reson Med 2000;43:368-74. (Pubitemid 30127523)
19. Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, et al. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 2005;92:1599-610. (Pubitemid 40756468)
20. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-32. (Pubitemid 29463104)
21. Galbraith SM, Lodge MA, Taylor NJ, Rustin GJ, Bentzen S, Stirling JJ, et al. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: compar-ison of quantitative and semi-quantitative analysis. NMR Biomed 2002;15:132-42. (Pubitemid 34213403)
22. Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med 2002;47:601-6. (Pubitemid 34194016)
23. Padhani AR, Hayes C, Landau S, Leach MO. Repro-ducibility of quantitative dynamic MRI of normal human tissues. NMR Biomed 2002;15:143-53. (Pubitemid 34213404)
24. Kostler H, Ritter C, Lipp M, Beer M, Hahn D, Sandstede J. Prebolus quantitative MR heart perfusion imaging. Magn Reson Med 2004;52:296-9. (Pubitemid 39025273)
25. Risse F, Semmler W, Kauczor HU, Fink C. Dual-bolus approach to quantitative measurement of pulmonary perfusion by contrast-enhanced MRI. J Magn Reson Imaging 2006;24:1284-90. (Pubitemid 44871872)
26. Parker GJ, Barker GJ, Tofts PS. Accurate multislice gradient echo T(1) measurement in the presence of non-ideal RF pulse shape and RF field nonuniformity. Magn Reson Med 2001;45:838-45. (Pubitemid 32402026)
27. Dowell NG, Tofts PS. Fast, accurate, and precise mapping of the RF field in vivo using the 180 degrees signal null. Magn Reson Med 2007;58:622-30. (Pubitemid 350154975)
28. 2 relaxation times of normal appearing white matter and lesions in multiple sclerosis. J Neurol Sci 2000;178:81-7.
29. Rutgers DR, van der GJ. Relaxation times of choline, creatine and N-acetyl aspartate in human cerebral white matter at 1.5 T. NMR Biomed 2002;15:215-21. (Pubitemid 34520661)
30. Ethofer T, Mader I, Seeger U, Helms G, Erb M, Grodd W, et al. Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla. Magn Reson Med 2003;50:1296-301. (Pubitemid 37494031)
31. Deoni SC. High-resolution T1 mapping of the brain at 3T with driven equilibrium single pulse observation of T1 with high-speed incorporation of RF field inhomogene-ities (DESPO T1-HIFI). J Magn Reson Imaging 2007; 26:1106-11. (Pubitemid 47548174)
32. 2 imaging at 1.5 T. Neuroimage 2008;40: 662-71.
33. Benner T, Reimer P, Erb G, Schuierer G, Heiland S, Fischer C, et al. Cerebral MR perfusion imaging: first clinical application of a 1 M gadolinium chelate (Gadovist 1.0) in a double-blinded randomized dose-finding study. J Magn Reson Imaging 2000;12:371-80.
34. Rana AK, Wardlaw JM, Armitage PA, Bastin ME. Apparent diffusion coefficient (ADC) measurements may be more reliable and reproducible than lesion volume on diffusion-weighted images from patients with acute ischaemic stroke-implications for study design. Magn Reson Imaging 2003;21:617-24. (Pubitemid 37046561)
35. Marks MP, de Crespigny A, Lentz D, Enzmann DR, Albers GW, Moseley ME. Acute and chronic stroke: navigated spin-echo diffusion-weighted MR imaging. Radiology 1996;199:403-8. (Pubitemid 26121985)
36. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G. Diffusion tensor MR imaging of the human brain. Radiology 1996;201:637-48.
37. Filippi M, Iannucci G, Cercignani M, Assunta RM, Pratesi A, Comi G. A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging. Arch Neurol 2000;57: 1017-21. (Pubitemid 30452507)
38. Ciccarelli O, Werring DJ, Wheeler-Kingshott CA, Barker GJ, Parker GJ, Thompson AJ, et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001;56:926-33. (Pubitemid 32290810)
39. Cercignani M, Inglese M, Pagani E, Comi G, Filippi M. Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol 2001;22:952-8. (Pubitemid 32436241)
40. Zhang L, Harrison M, Heier LA, Zimmerman RD, Ravdin L, Lockshin M, et al. Diffusion changes in patients with systemic lupus erythematosus. Magn Reson Imaging 2007;25:399-405. (Pubitemid 46413649)
41. Welsh RC, Rahbar H, Foerster B, Thurnher M, Sundgren PC Brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus with new acute neurolo-gical symptoms. J Magn Reson Imaging 2007;26:541-51. (Pubitemid 350194574)
42. Emmer BJ, van der Grond J, Steup-Beekman GM, Huizinga TW, van Buchem MA. Selective involvement of the amygdala in systemic lupus erythematosus. PLoS Med 2006;3:e499.
43. Clark CA, Hedehus M, Moseley ME. In vivo mapping of the fast and slow diffusion tensors in human brain. Magn Reson Med 2002;47:623-8. (Pubitemid 34263773)
44. Steens SC, Admiraal-Behloul F, Schaap JA, Hoogenraad FG, Wheeler-Kingshott CA, Le Cessie S, et al. Re-producibility of brain ADC histograms. Eur Radiol 2004;14:425-30.
45. Wheeler-Kingshott C, Barker GJ, Steens SCA, van Buchem MA. D: the diffusion of water. In: Tofts PS, ed. Quantitative MRI of the brain: measuring changes caused by disease. Chichester, UK: John Wiley, 2003: 203-56.
46. Marenco S, Rawlings R, Rohde GK, Barnett AS, Honea RA, Pierpaoli C, et al. Regional distribution of measurement error in diffusion tensor imaging. Psychiatry Res 2006;147: 69-78. (Pubitemid 44088607)
47. Pfefferbaum A, Adalsteinsson E, Sullivan EV. Repli-cability of diffusion tensor imaging measurements of fractional anisotropy and trace in brain. J Magn Reson Imaging 2003;18:427-33. (Pubitemid 37187595)
48. Holz M, Heil SR, Sacco A. Temperature-dependent self-diffusion coefficients of water and six selected molecular liquids for calibration in accurate H-1 NMR PFG measurements. Phys Chem Chem Phys 2000;2:4740-2.
49. Laubach HJ, Jakob PM, Loevblad KO, Baird AE, Bovo MP, Edelman RR, et al. A phantom for diffusion-weighted imaging of acute stroke. J Magn Reson Imaging 1998;8:1349-54. (Pubitemid 28533685)
50. Delakis I, Moore EM, Leach MO, De Wilde JP. Developing a quality control protocol for diffusion imaging on a clinical MRI system. Phys Med Biol 2004;49:1409-22. (Pubitemid 38578494)
51. Mills R. Self-diffusion in normal and heavy water in the range 1-45°. J Phys Chem 1973;77:685-8.
52. Tofts PS, Jackson JS, Tozer DJ, Cercignani M, Keir G, MacManus DG, et al. Imaging cadavers: cold FLAIR and noninvasive brain thermometry using CSF diffusion. Magn Reson Med 2008;59:190-5.
53. Rashid W, Hadjiprocopis A, Davies G, Griffin C, Chard D, Tiberio M, et al. Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffu-sion tensor imaging. J Neurol 2008;255:390-7.
54. Bisdas S, Bohning DE, Besenski N, Nicholas JS, Rumboldt Z. Reproducibility, interrater agreement, and age-related changes of fractional anisotropy measures at 3T in healthy subjects: effect of the applied b-value. AJNR Am J Neuroradiol 2008;29:1128-33. (Pubitemid 351954880)
55. Oouchi H, Yamada K, Sakai K, Kizu O, Kubota T, Ito H, et al. Diffusion anisotropy measurement of brain white matter is affected by voxel size: underestimation occurs in areas with crossing fibers. AJNR Am J Neuroradiol 2007;28:1102-6. (Pubitemid 46984552)
56. Chang LC, Jones DK, Pierpaoli C. RESTORE: robust estimation of tensors by outlier rejection. Magn Reson Med 2005;53:1088-95. (Pubitemid 40627784)
57. Ozturk A, Sasson AD, Farrell JA, Landman BA, da Motta AC, Aralasmak A, et al. Regional differences in diffusion tensor imaging measurements: assessment of intrarater and interrater variability. AJNR Am J Neuroradiol 2008;29:1124-7 (Pubitemid 351954879)
58. Yanasak NE, Allison JD, Hu TC. An empirical character-ization of the quality of DTI data and the efficacy of dyadic sorting. Magn Reson Imaging 2008;26:122-32. (Pubitemid 350299732)
59. Fieremans E, De Deene Y, Delputte S, Ozdemir MS, D'Asseler Y, Vlassenbroeck J, et al. Simulation and experimental verification of the diffusion in an aniso-tropic fiber phantom. J Magn Reson 2008;190:189-99.
60. Sasaki M, Yamada K, Watanabe Y, Matsui M, Ida M, Fujiwara S, et al. Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology 2008;249:624-30.
61. Cercignani M, Bammer R, Sormani MP, Fazekas F, Filippi M. Inter-sequence and inter-imaging unit variability of diffusion tensor MR imaging histogram-derived metrics of the brain in healthy volunteers. AJNR Am J Neuroradiol 2003;24:638-43. (Pubitemid 36460732)
62. Berry I, Barker GJ, Barkhof F, Campi A, Dousset V, Franconi JM, et al. A multicenter measurement of magnetization transfer ratio in normal white matter. J Magn Reson Imaging 1999;9:441-6. (Pubitemid 29180139)
63. Silver NC, Barker GJ, MacManus DG, Tofts PS, Miller DH. Magnetisation transfer ratio of normal brain white matter: a normative database spanning four decades of life. J Neurol Neurosurg Psychiatry 1997;62:223-8. (Pubitemid 27117247)
64. Davies GR, Altmann DR, Hadjiprocopis A, Rashid W, Chard DT, Griffin CM, et al. Increasing normal-appear-ing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. J Neurol 2005;252:1037-44. (Pubitemid 41355832)
65. Mendelson DA, Heinsbergen JF, Kennedy SD, Szczepaniak LS, Lester CC, Bryant RG. Comparison of agarose and cross-linked protein gels as magnetic resonance imaging phantoms. Magn Reson Imaging 1991;9:975-8.
66. Tozer D, Ramani A, Barker GJ, Davies GR, Miller DH, Tofts PS. Quantitative magnetization transfer mapping of bound protons in multiple sclerosis. Magn Reson Med 2003;50:83-91. (Pubitemid 36841863)
67. Tofts PS, Cercignani M, Tozer DJ, Symms MR, Davies GR, Ramani A, et al. Quantitative magnetization transfer mapping of bound protons in multiple sclerosis, Magn Reson Med 2003;50:83-91. (Pubitemid 36841863)
68. Erratum in: Magn Reson Med 2005;53:492-3.
69. Tozer D, Benton CE, Cercignani M, Tofts PS, Rees J. Quantitative Magnetisation Transfer Parameters show Dramatic Changes in Low Grade Gliomas. Proceedings of the International Society Magnetic Resonance in Medicine, 15th annual meeting, Berlin. 2007; 2852.
70. McKnight TR. Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism. Semin Oncol 2004; 31:605-17. (Pubitemid 39389012)
71. Payne GS, Leach MO. Applications of magnetic reso-nance spectroscopy in radiotherapy treatment planning. Br J Radiol 2006;79:S16-26. (Pubitemid 44614400)
72. Kreis R. Quantitative localized 1H MR spectroscopy for clinical use. Prog Nucl Magn Reson Spectrosc 1997;31: 155-95. (Pubitemid 127427694)
73. 1H metabolite concentrations. In: Tofts PS, ed. Quantitative MRI of the brain: measuring changes caused by disease. Chichester, UK: John Wiley 2003:299-339.
74. Leach MO, Collins DJ, Keevil S, Rowland I, Smith MA, Henriksen O, et al. Quality assessment in in vivo NMR spectroscopy: III. Clinical test objects: design, con-struction, and solutions. Magn Reson Imaging 1995; 13:131-7.
75. van der Graaf M, Julia-Sape M, Howe FA, Ziegler A, Majos C, Moreno-Torres A, et al. MRS quality assess-ment in a multicentre study on MRS-based classifi-cation of brain tumours. NMR Biomed 2008;21:148-58. (Pubitemid 351351007)
76. Keevil SF, Barbiroli B, Collins DJ, Danielsen ER, Hennig J, Henriksen O, et al. Quality assessment in in vivo NMR spectroscopy: IV. A multicentre trial of test objects and protocols for performance assessment in clinical NMR spectroscopy. Magn Reson Imaging 1995; 13:139-57.
77. Garcia-Gomez JM, Luts J, Julia-Sape M, Krooshof P, Tortajada S, Robledo JV, et al. Multiproject-multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy. MAGMA 2009;22: 5-18.
78. Soher BJ, Hurd RE, Sailasuta N, Barker PB. Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference. Magn Reson Med 1996;36:335-9. (Pubitemid 26299257)
79. Keevil SF, Barbiroli B, Brooks JC, Cady EB, Canese R, Carlier P, et al. Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. Magn Reson Imaging 1998;16:1093-106. (Pubitemid 29189665)
80. Brooks WM, Friedman SD, Stidley CA. Reproducibility of 1H-MRS in vivo. Magn Reson Med 1999;41:193-7.
81. Schirmer T, Auer DP. On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain. NMR Biomed 2000;13:28-36. (Pubitemid 30136999)
82. Naressi A, Couturier C, Castang I, de Beer R, Graveron-Demilly D. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med 2001;31:269-86. (Pubitemid 32378728)
83. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14
84. Jager HR, Waldman AD, Benton C, Fox N, Rees J. Differential chemosensitivity of tumor components in a malignant oligodendroglioma: assessment with diffu-sion-weighted, perfusion-weighted, and serial volu-metric MR imaging. AJNR Am J Neuroradiol 2005;26: 274-8. (Pubitemid 43073304)
85. Rees J, Watt H, Jager HR, Benton C, Tozer D, Tofts P, et al. Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation. Eur J Radiol 2009;72:54-64.
86. Galanis E, Buckner JC, Maurer MJ, Sykora R, Castillo R, Ballman KV, et al. Validation of neuroradiologic res-ponse assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods. Neuro Oncol 2006;8:156-65. (Pubitemid 46542660)
87. Shah GD, Kesari S, Xu R, Batchelor TT, O'Neill AM, Hochberg FH, et al. Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas. Neuro Oncol 2006;8:38-46. (Pubitemid 43154449)
88. Bynevelt M, Britton J, Seymour H, MacSweeney E, Thomas N, Sandhu K. FLAIR imaging in the follow-up of low-grade gliomas: time to dispense with the dual-echo? Neuroradiology 2001;43:129-33. (Pubitemid 32156702)
89. Tofts PS, Barker GJ, Filippi M, Gawne-Cain M, Lai M. An oblique cylinder contrast-adjusted (OCCA) phantom to measure the accuracy of MRI brain lesion volume estimation schemes in multiple sclerosis. Magn Reson Imaging 1997;15:183-92. (Pubitemid 27173232)
90. Parkes LM. Quantification of cerebral perfusion using arterial spin labeling: two-compartment models. J Magn Reson Imaging 2005;22:732-6. (Pubitemid 41741239)
91. Xie J, Gallichan D, Gunn RN, Jezzard P. Optimal design of pulsed arterial spin labeling MRI experiments. Magn Reson Med 2008;59:826-34. (Pubitemid 351501949)
92. Alsop DC, Detre JA. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 1996; 16:1236-49. (Pubitemid 26365376)
93. Luh WM, Wong EC, Bandettini PA, Hyde JS. QUIPSS II with thin-slice TI1 periodic saturation: a method for improving accuracy of quantitative perfusion imaging using pulsed arterial spin labeling. Magn Reson Med 1999;41:1246-54. (Pubitemid 29247294)
94. Ye FQ, Mattay VS, Jezzard P, Frank JA, Weinberger DR, McLaughlin AC Correction for vascular artifacts in cerebral blood flow values measured by using arterial spin tagging techniques. Magn Reson Med 1997;37:226-35. (Pubitemid 27045395)
95. Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 1998;40:383-96. (Pubitemid 28391899)
96. Parkes LM, Tofts PS. Improved accuracy of human cerebral blood perfusion measurements using arterial spin labeling: accounting for capillary water permeabil-ity. Magn Reson Med 2002;48:27-41. (Pubitemid 34721585)
97. Parkes LM, Rashid W, Chard DT, Tofts PS. Normal cerebral perfusion measurements using arterial spin labeling: reproducibility, stability, and age and gender effects. Magn Reson Med 2004;51:736-43. (Pubitemid 38420450)
98. Petersen ED, Golay X. Is Arterial Spin Labeling Ready for Primetime? Preliminary Results from the QUASAR reproducibility study. Proceedings of the International Society Magnetic Resonance in Medicine, 16th annual meeting, Toronto 2008; 191.
99. Miles KA. Perfusion imaging with computed tomo-graphy: brain and beyond. Eur Radiol 2006;16:S37-43.
100. Hoeffner EG, Case I, Jain R, Gujar SK, Shah GV, Deveikis JP, et al. Cerebral perfusion CT: technique and clinical applications. Radiology 2004;231:632-44. (Pubitemid 38668077)
101. Szucs-Farkas Z, Kurmann L, Strautz T, Patak MA, Vock P, Schindera ST. Patient exposure and image quality of low-dose pulmonary computed tomography angiogra-phy: comparison of 100-and 80-kVp protocols. Invest Radiol 2008;43:871-6.
102. Tan JS, Tan KL, Lee JC, Wan CM, Leong JL, Chan LL. Comparison of Eye Lens Dose on Neuroimaging Protocols between 16-and 64-Section Multidetector CT: Achieving the Lowest Possible Dose. AJNR Am J Neuroradiol 2009;30:373-7.
103. Goh V, Halligan S, Bartram CI. Quantitative tumor perfusion assessment with multidetector CT: are measure-ments from two commercial software packages inter-changeable? Radiology 2007;242:777-82.
104. Ropele S, Filippi M, Valsasina P, Korteweg T, Barkhof F, Tofts PS, et al. Assessment and correction of B(1)-induced errors in magnetization transfer ratio measure-ments. Magn Reson Med 2005;53:134-40. (Pubitemid 40110486)
105. Beresford MJ, Padhani AR, Taylor NJ, Ah-See ML, Stirling JJ, Makris A, et al. Inter-and intraobserver variability in the evaluation of dynamic breast cancer MRI. J Magn Reson Imaging 2006;24:1316-25. (Pubitemid 44871877)
106. O'Connor JPB, Tofts PS, Miles KA, Parkes LM, Thompson G and Jackson A. Dynamic contrast-enhanced imaging techniques: CT and MRI. Br J Radiol 2011;84(Spec. No. 2):S112-20.
107. Reynolds G, Wilson M, Peet A, Arvanitis TN. An algorithm for the automated quantitation of metabolites in in vivo NMR signals. Magn Reson Med 2006;56: 1211-19. (Pubitemid 44865302)
108. Dowell NG, Tofts PS. Quality assurance for diffusion MRI. In Jones DK, ed. Diffusion: theory, methods and applications. New York: Oxford University Press, 2011: 319-30.